CN108251441A - A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome - Google Patents

A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome Download PDF

Info

Publication number
CN108251441A
CN108251441A CN201711462380.0A CN201711462380A CN108251441A CN 108251441 A CN108251441 A CN 108251441A CN 201711462380 A CN201711462380 A CN 201711462380A CN 108251441 A CN108251441 A CN 108251441A
Authority
CN
China
Prior art keywords
fusion protein
leu
thr
ala
gln
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711462380.0A
Other languages
Chinese (zh)
Inventor
卢艳华
周志伟
付卫雷
夏坤
佟顺刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Tianbao Songyuan Biology Science & Technology Development Co Ltd
Original Assignee
Guangzhou Tianbao Songyuan Biology Science & Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Tianbao Songyuan Biology Science & Technology Development Co Ltd filed Critical Guangzhou Tianbao Songyuan Biology Science & Technology Development Co Ltd
Priority to CN201711462380.0A priority Critical patent/CN108251441A/en
Publication of CN108251441A publication Critical patent/CN108251441A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome, fusion protein includes the GAF structural domains and Streptavidin of cyanobacteria phytochrome protein alr3356.The fusion protein sequence of the present invention is easy to stablize expression in microorganism, and the acquisition for having evaded high-purity natural phycobniliprotein and cyanobacteria phytochrome is difficult, and manufacturing cost is higher；The use of chemical modifier；The shortcomings of naturally phycobniliprotein polymeric species are unstable.The expression of the present invention is participated in without phycobniliprotein lyase, reduces the gene dosage of conversion, improves strain stability and screening efficiency.Simultaneously by optimizing fermentation medium and fermentation condition, the yield of fusion protein is substantially increased.

Description

A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome
Technical field
The present invention relates to expressing fusion protein field, more particularly to a kind of preparation method of phytochrome fluorescent marker.
Background technology
Fluorescence probe (or fluorescent marker) is the important foundation raw material of fluorescence immunoassay detection technique, mainly passes through chemistry The same biotin of fluorogenic substrate-Streptavidin system is combined and obtained, fluorescence signal can be further amplified, raising is exempted from by modification method The sensitivity of epidemic disease detection.
Natural phycobniliprotein is one of most common fluorogenic substrate, and natural structure is generally six aggressiveness, and subunit is by de- auxiliary Base albumen and phycobilin are formed by lyase catalyzed combination.Phycobilin then passes through heme oxidase by ferroheme (HO1) and various biliverdin reductases are catalyzed to be formed, and common phycobilin has a phycoerythrobilin (PEB), phycourobilin (PUB), Phycocyanobilin (PCB) and algae purple Choline (PVB).By combining different phycobilins, phycobniliprotein absorbs 400nm~700nm In the range of different-waveband light after, different fluorescence can be sent out.
Traditional Zao Bie Ruan Gang Tang preparation flow is to obtain high-purity natural phycobniliprotein first, then passes through Chemical modification method is combined with biotin-Streptavidin system, immune detection is used further to after being further purified.But high-purity Natural phycobniliprotein obtain difficult, manufacturing cost is high, while structural instability, polymeric species are changeable.This causes phycobniliprotein The cost of fluorescence probe remains high.
It is a kind of lower-cost protein preparation method by microbial expression fusion protein.However the expression of fusion protein The design of fusion and the limitation of zymotechnique are suffered from, the expression that can not stablize, it is difficult to obtain the conjunction of stable quality Lattice product.
Suitable albumen segment how to be selected to be merged so that it can more steadily fermenting and producing, be have it is to be solved The technical issues of.
Invention content
It is an object of the invention to overcome the deficiencies of the prior art and provide it is a kind of be easy to expression fusion protein sequence and its Expression.
The technical solution used in the present invention is：
A kind of fusion protein, GAF structural domains and Streptavidin including cyanobacteria phytochrome protein alr3356.
As being further improved for above-mentioned fusion protein, affinity labeling is also added in fusion protein.
As being further improved for above-mentioned fusion protein, the sequence of fusion protein is： MGSSHHHHHHSQDPEAGITGTWYNQLGSTFIVTAGADGALTGTYESAVGNAESRYVLTGRYDSAPATDGSGTALGWT VAWKNNYRNAHSATTWSGQYVGGAEARINTQWLLTSGTTEANAWKSTLVGHDTFTKVKPSAASGSGTDDDDKAMADG MQIHSHAEFDPSSNKPTEQGLQKVLQRLVQTMQRDALVRQTTNQLRESLQVDRVVLYYFYWQWHGQVTFEALSSEEF SILGSTGADECFNDEYAALYLAGRTKAIADIESEPITTCHRDFLRTLQVRANLVVPVLVPKGLWGLLVAHHCQGTHD WKESDIELMQAGAKTLATSPYILE。
Express the nucleotide sequence of above-mentioned fusion protein.Further, nucleotide sequence carries out codon according to host strain Optimization.
Plasmid inserted with above-mentioned nucleotide sequence.
As being further improved for above-mentioned plasmid, plasmid is pET Duet vector plasmids, and nucleotide sequence passes through digestion position Point BamH I, EcoR I are inserted into the multiple cloning sites 1 of pET Duet vector plasmids.
A kind of preparation method of fusion protein, includes the following steps：
1) according to the sequence of above-mentioned fusion protein, design obtains antigen-4 fusion protein gene sequence；
2) antigen-4 fusion protein gene sequence is inserted into plasmid, obtains fusion protein plasmid；
3) by fusion protein plasmid and the related gene of expression phycoerythrobilin synthesis：Heme oxidase gene ho1, courage are green The plasmid corotation of plain reductase gene pebS enters Escherichia coli, obtains genetic engineering bacterium；
4) it is inoculated with genetic engineering bacterium in the medium using three-level inoculation method, 37 DEG C of fermented and cultureds are to growing early period；
5) 20 DEG C are cooled to, cultivates 0.8~1.2h；
6) 25 DEG C are warming up to, adds in 14~16h of lactose Fiber differentiation that whole mass concentration is 1.3~1.6%；
7) thalline extraction is collected, purifying obtains fusion protein.
As being further improved for above-mentioned preparation method, the quality group of fermentation medium becomes：Peptone 1%, dusty yeast 0.5%, sodium chloride 1%, glycerine 0.4%, 0.004%~0.04% proteinic powder of porcine or ferroheme, surplus is water, pH value tune To 7.2.
As being further improved for above-mentioned preparation method, the lactose Fiber differentiation that whole mass concentration is 1.5% is added in.
The beneficial effects of the invention are as follows：
The fusion protein sequence of the present invention is easy to stablize expression in microorganism, has evaded high-purity natural phycobniliprotein Acquisition with cyanobacteria phytochrome is difficult, and manufacturing cost is higher；The use of chemical modifier；Natural phycobniliprotein polymeric species The shortcomings of unstable.
The expression of the present invention is participated in without phycobniliprotein lyase, reduces the gene dosage of conversion, and it is steady to improve strain Qualitative and screening efficiency.Simultaneously by optimizing fermentation medium and fermentation condition, the yield of fusion protein is substantially increased.
Description of the drawings
Fig. 1 is the spectral signature figure of phytochrome fluorescent marker；
Fig. 2 is the spectral signature figure of phytochrome fluorescent marker (control)；
Fig. 3 is the ferment effect comparison of different fermentations culture medium.
Specific embodiment
With reference to embodiment, the technical solution further illustrated the present invention.
Embodiment 1
The selection of cyanobacteria phytochrome GAF domain sequences
Cyanobacteria phytochrome gene order alr3356 (algae PCC7120), there are the higher GAF knots of 1 homology Structure domain, this programme choose the GAF domain genes sequence hereinafter referred to as gaf gene orders.Its gal4 amino acid after expressing Sequence is as follows：
MQIHSHAEFDPSSNKPTEQGLQKVLQRLVQTMQRDALVRQTTNQLRESLQVDRVVLYYFYWQWHGQVTFEALSSEEF SILGSTGADECFNDEYAALYLAGRTKAIADIESEPITTCHRDFLRTLQVRANLVVPVLVPKGLWGLLVAHHCQGTHD WKESDIELMQAGAKTLATSPYILE(SEQ ID NO：1).
The selection of transgenosis plasmid combinations
This programme is combined using Duet series double-mass model, sa::The multiple cloning sites of gaf fusions access pET Duet 1；Phycoerythrobilin synzyme plasmid uses pACYC Duet-ho1-pebS.
Streptavidin sa sequences and gaf sequences, 6his-taq affinity labelings sequence carry out Combined design, and for large intestine Bacillus expression system carries out gene order optimization.Final sa::Fused protein amino acid sequence expressed by gaf gene orders It is as follows：
MGSSHHHHHHSQDPEAGITGTWYNQLGSTFIVTAGADGALTGTYESAVGNAESRYVLTGRYDSAPATDGSGTALGWT VAWKNNYRNAHSATTWSGQYVGGAEARINTQWLLTSGTTEANAWKSTLVGHDTFTKVKPSAASGSGTDDDDKAMADG MQIHSHAEFDPSSNKPTEQGLQKVLQRLVQTMQRDALVRQTTNQLRESLQVDRVVLYYFYWQWHGQVTFEALSSEEF SILGSTGADECFNDEYAALYLAGRTKAIADIESEPITTCHRDFLRTLQVRANLVVPVLVPKGLWGLLVAHHCQGTHD WKESDIELMQAGAKTLATSPYILE(SEQ ID NO：2).
By restriction enzyme site BamH I (GGATCC), EcoR I (GAATTC) access pET Duet are carried gene order after fusion The multiple cloning sites 1 (MCS1) of constitution grain, obtain plasmid pET Duet-sa::gaf.
Strain prepares screening
1) from picking coli strain BL21 (DE3) single bacterium colony on the tablet of fresh coating, 5mL LB cultures are inoculated in Base, 37 DEG C of shaken cultivations are stayed overnight；
2) 100 μ L saturated cultures are taken, it is sterile to be forwarded to 5mL LB culture mediums, 37 DEG C of shaken cultivations to OD600=0.3~ When 0.4, bacterium solution is transferred in 5mL sterile centrifugation tubes, places 10min on ice；Centrifugation 1min (10000g, 4 DEG C) is discarded supernatant, Collect precipitation thalline；
3) 0.1mol/LCaCl being pre-chilled with 1mL2Thalline is resuspended in sterile solution, and centrifugation 30s (10000g, 4 DEG C) removes supernatant, The 0.1mol/L CaCl that bacterial sediment is pre-chilled with 100 μ L2It is resuspended, is positioned on ice, adds in a certain amount of plasmid built, Ice bath places 30min after mixing, and 300 μ L LB culture mediums, 37 DEG C of low-speed oscillation trainings are added in after 42 DEG C of heat shock 90s, ice bath 5min 45min is supported, on the sterile LB culture medium flat plates being coated on containing corresponding antibiotic, it is visible to being formed to be inverted in 37 DEG C of incubators Monoclonal bacterial plaque.
The experiment proved that the clump count of this programme culture is probably 1~102, and the Zao Bie Ruan Gang Tang under the conditions of Three plasmid combinations conversion scheme culture clump count probably 1~10.The genetic engineering bacterium screening efficiency higher of this programme.
A small amount of expression
The monoclonal strain that picking is come out, is inoculated in by sterile working in 4 shaking flasks, each shaking flask 300mL LB trainings Support base, 37 DEG C of shaken cultivations to OD600It is 0.3 to 0.4；Then shaking flask ice-water bath cooling 0.5h；Addition isopropylthio-β- To final concentration of 1mmol/L, 20 DEG C vibrate D- galactosides (isoprophylthio- β-D-galactoside, abbreviation IPTG) Expression about 12 hours；8000g thalline were collected by centrifugation cells.
Fermentation
1) level-one kind liquid is prepared：Qualified 20 μ L of monoclonal strain kind liquid are taken, are accessed in 25mL LB culture mediums, 37 DEG C low Fast shaken overnight culture is to saturated concentration；
2) two level kind liquid is prepared：5mL level-one kind liquid is transferred in 1.5L LB culture mediums, 37 DEG C of middling speed shaken cultivations 3~ 4h, OD600Control is below 0.5；
3) it is inoculated with：1.5L two level kind liquid is forwarded in 200L fermentation tanks, culture medium 150L, fermentative medium formula：Egg White peptone 1%, dusty yeast 0.5%, sodium chloride 1%, glycerine 0.4%, 0.04% proteinic powder of porcine, pH value are adjusted to NaOH solution 7.2；
4) it cultivates：37 DEG C, the culture of 300rpm middling speeds to growing early period, when be about 1h；
5) cool down：The setting of tank temperature is down to 20 DEG C, and rotating speed is down to 150rpm, and when low speed culture is about 1h；
6) it induces：Add in lactose final concentration about 1.5%, 25 DEG C, 150rpm low speed cultures, when induced expression is about 16h；
7) tank under：Wet thallus is collected in centrifugation.
Ferment effect is evaluated：Take the wet thallus of 1g weight, with 5mL phosphate buffers (20mM KPP, 0.5M NaCl, PH7.2 after) being resuspended, sampling carries out fluorescence emission spectrum detection.Ferment effect is assessed according to the fluorescence volume of unit mass wet thallus.
Extraction
1) wet thallus is resuspended according to 20% ratio with the phosphate buffer (20mM KPP, 0.5M NaCl) of pH7.2；
2) ultrasonication is extracted, power 250W, time 1s, is spaced 3s, total duration 5min；(or freeze-thaw method extraction, repeatedly Freeze thawing 3 times freezes at least 2h every time)；
3) 10000g, 10min, repeated centrifugation twice, take supernatant；
4) 0.45 μm of aperture water system membrane filtration, takes supernatant.
Purifying
Nickel ion chelating gel affinity chromatography.After loading, 50mM imidazole solutions elution impurity, fraction collection sample.pH7.2 Phosphate buffer (20mM KPP, 0.5M NaCl) dialysis remove imidazoles.
Sample after purification, carries out fluorescence emission spectrum detection and absorption spectrum scans, scanning range 300nm~800nm, Detection data can be used for the fluorescence property of assessment product.Its characteristic absorption and fluorescence spectrum are as shown in Figure 1.In figure, solid line is glimmering Optical emission spectroscopy, excitation wavelength 520nm, scanning range 300nm~700nm；Dotted line is visible absorption spectra, scanning range 300nm~700nm.The GAF structural domain fluorescence properties of marker selection are splendid, are suitable for immune labeled.
Comparative example 1：
With embodiment 1, the protein amino acid sequence after being expressed the difference lies in GAF structural domains is as follows：
QQYQHTLLLKQITEEIRQSLQWEKILKTTVTEVQRILQVDRALIFQINSDGSGKVVQEAVMPGWSVTLDQDIYDPCL KDGYLNMYRDGRITAIADVYQGGLKPCYVEFLQQFQVKANLVVPIRVRRNLWGLLIVHQCDRPRQWTELELDLLKHL ADQMGIALTQSQLLAQETRQA(SEQID NO：3), the fused protein amino acid sequence expressed by final gene order is such as Under：
MGSSHHHHHHSQDPEAGITGTWYNQLGSTFIVTAGADGALTGTYESAVGNAESRYVLTGRYDSAPATDGSGTALGWT VAWKNNYRNAHSATTWSGQYVGGAEARINTQWLLTSGTTEANAWKSTLVGHDTFTKVKPSAASGSGTDDDDKAMADG QQYQHTLLLKQITEEIRQSLQWEKILKTTVTEVQRILQVDRALIFQINSDGSGKVVQEAVMPGWSVTLDQDIYDPCL KDGYLNMYRDGRITAIADVYQGGLKPCYVEFLQQFQVKANLVVPIRVRRNLWGLLIVHQCDRPRQWTELELDLLKHL ADQMGIALTQSQLLAQETRQA(SEQ ID NO：4)
It purifies obtained fusion protein characteristic absorption and fluorescence spectrum is as shown in Figure 2.In Fig. 2, solid line is fluorescent emission Spectrum, excitation wavelength are respectively 460nm and 520nm, scanning range 300nm~800nm；Dotted line is visible absorption spectra, scanning Range 300nm~800nm.
By comparison diagram 1 and Fig. 2 it is found that the GAF structural domain fluorescence properties of comparative example are poor, the properties of product phase with Fig. 1 Poor 10 times or more, it is impossible to be used in immune detection.
Influence of the different fermentations culture medium to ferment effect
Embodiment 2：
The monoclonal strain that the fermentation of Example 1 uses, ferments as follows.
1) level-one kind liquid is prepared：Qualified 20 μ L of monoclonal strain kind liquid are taken, are accessed in 25mL LB culture mediums, 37 DEG C low Fast shaken overnight culture is to saturated concentration；
2) two level kind liquid is prepared：5mL level-one kind liquid is transferred in 1.5L LB culture mediums, 37 DEG C of middling speed shaken cultivations 3~ 4h, OD600Control is below 0.5；
3) it is inoculated with：1.5L two level kind liquid is forwarded in 200L fermentation tanks, culture medium 150L, fermentative medium formula：Egg White peptone 1%, dusty yeast 0.5%, sodium chloride 1%, glycerine 0.4%, 0.004% ferroheme, pH value are adjusted to 7.2 with NaOH solution；
4) it cultivates：37 DEG C, the culture of 300rpm middling speeds to growing early period, when be about 1h；
5) cool down：The setting of tank temperature is down to 20 DEG C, and rotating speed is down to 150rpm, and when low speed culture is about 1h；
6) it induces：Add in lactose final concentration about 1.5%, 25 DEG C, 150rpm low speed cultures, when induced expression is about 16h；
7) tank under：Wet thallus is collected in centrifugation.
Embodiment 3：
The monoclonal strain that the fermentation of Example 1 uses, ferments as follows.
1) level-one kind liquid is prepared：Qualified 20 μ L of monoclonal strain kind liquid are taken, are accessed in 25mL LB culture mediums, 37 DEG C low Fast shaken overnight culture is to saturated concentration；
2) two level kind liquid is prepared：5mL level-one kind liquid is transferred in 1.5L LB culture mediums, 37 DEG C of middling speed shaken cultivations 3~ 4h, OD600Control is below 0.5；
3) it is inoculated with：1.5L two level kind liquid is forwarded in 200L fermentation tanks, culture medium 150L, fermentative medium formula：Egg White peptone 1%, dusty yeast 0.5%, sodium chloride 1%, glycerine 0.4%, pH value is adjusted to 7.2 with NaOH solution；
4) it cultivates：37 DEG C, the culture of 300rpm middling speeds to growing early period, when be about 1h；
5) cool down：The setting of tank temperature is down to 20 DEG C, and rotating speed is down to 150rpm, and when low speed culture is about 1h；
6) it induces：Add in lactose final concentration about 1.5%, 25 DEG C, 150rpm low speed cultures, when induced expression is about 16h；
7) tank under：Wet thallus is collected in centrifugation.
Embodiment 1, embodiment 2 and embodiment 3 have been respectively adopted different fermentative medium formulas, and formula components are consistent Part all employs same batch raw material.Its ferment effect compares as shown in figure 3, embodiment 1 and embodiment 2 are after optimizing Culture medium, embodiment 3 are traditional culture medium.The fluorescence property of Examples 1 and 2 tunning improves closely compared with embodiment 3 50%, meet purity Coriolis mass requirement, illustrate that its culture medium composition is more advantageous to the expression of fusion protein.
Expression stability：
Respectively by the zymotechnique of embodiment 1 and the zymotechnique fermenting and producing fusion protein 3 batches of embodiment 2, find to melt The expression quantity of hop protein is highly stable, and the deviation of average expression amount is within 5%.
SEQUENCE LISTING
<110>Guangzhou Tianbao Songyuan Biology Science ＆ Technology Development Co., Ltd.
<120>A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome
<130> 5
<160> 4
<170> PatentIn version 3.5
<210> 1
<211> 178
<212> PRT
<213>Algae PCC7120
<400> 1
Met Gln Ile His Ser His Ala Glu Phe Asp Pro Ser Ser Asn Lys Pro
1 5 10 15
Thr Glu Gln Gly Leu Gln Lys Val Leu Gln Arg Leu Val Gln Thr Met
20 25 30
Gln Arg Asp Ala Leu Val Arg Gln Thr Thr Asn Gln Leu Arg Glu Ser
35 40 45
Leu Gln Val Asp Arg Val Val Leu Tyr Tyr Phe Tyr Trp Gln Trp His
50 55 60
Gly Gln Val Thr Phe Glu Ala Leu Ser Ser Glu Glu Phe Ser Ile Leu
65 70 75 80
Gly Ser Thr Gly Ala Asp Glu Cys Phe Asn Asp Glu Tyr Ala Ala Leu
85 90 95
Tyr Leu Ala Gly Arg Thr Lys Ala Ile Ala Asp Ile Glu Ser Glu Pro
100 105 110
Ile Thr Thr Cys His Arg Asp Phe Leu Arg Thr Leu Gln Val Arg Ala
115 120 125
Asn Leu Val Val Pro Val Leu Val Pro Lys Gly Leu Trp Gly Leu Leu
130 135 140
Val Ala His His Cys Gln Gly Thr His Asp Trp Lys Glu Ser Asp Ile
145 150 155 160
Glu Leu Met Gln Ala Gly Ala Lys Thr Leu Ala Thr Ser Pro Tyr Ile
165 170 175
Leu Glu
<210> 2
<211> 332
<212> PRT
<213>Fusion protein
<400> 2
Met Gly Ser Ser His His His His His His Ser Gln Asp Pro Glu Ala
1 5 10 15
Gly Ile Thr Gly Thr Trp Tyr Asn Gln Leu Gly Ser Thr Phe Ile Val
20 25 30
Thr Ala Gly Ala Asp Gly Ala Leu Thr Gly Thr Tyr Glu Ser Ala Val
35 40 45
Gly Asn Ala Glu Ser Arg Tyr Val Leu Thr Gly Arg Tyr Asp Ser Ala
50 55 60
Pro Ala Thr Asp Gly Ser Gly Thr Ala Leu Gly Trp Thr Val Ala Trp
65 70 75 80
Lys Asn Asn Tyr Arg Asn Ala His Ser Ala Thr Thr Trp Ser Gly Gln
85 90 95
Tyr Val Gly Gly Ala Glu Ala Arg Ile Asn Thr Gln Trp Leu Leu Thr
100 105 110
Ser Gly Thr Thr Glu Ala Asn Ala Trp Lys Ser Thr Leu Val Gly His
115 120 125
Asp Thr Phe Thr Lys Val Lys Pro Ser Ala Ala Ser Gly Ser Gly Thr
130 135 140
Asp Asp Asp Asp Lys Ala Met Ala Asp Gly Met Gln Ile His Ser His
145 150 155 160
Ala Glu Phe Asp Pro Ser Ser Asn Lys Pro Thr Glu Gln Gly Leu Gln
165 170 175
Lys Val Leu Gln Arg Leu Val Gln Thr Met Gln Arg Asp Ala Leu Val
180 185 190
Arg Gln Thr Thr Asn Gln Leu Arg Glu Ser Leu Gln Val Asp Arg Val
195 200 205
Val Leu Tyr Tyr Phe Tyr Trp Gln Trp His Gly Gln Val Thr Phe Glu
210 215 220
Ala Leu Ser Ser Glu Glu Phe Ser Ile Leu Gly Ser Thr Gly Ala Asp
225 230 235 240
Glu Cys Phe Asn Asp Glu Tyr Ala Ala Leu Tyr Leu Ala Gly Arg Thr
245 250 255
Lys Ala Ile Ala Asp Ile Glu Ser Glu Pro Ile Thr Thr Cys His Arg
260 265 270
Asp Phe Leu Arg Thr Leu Gln Val Arg Ala Asn Leu Val Val Pro Val
275 280 285
Leu Val Pro Lys Gly Leu Trp Gly Leu Leu Val Ala His His Cys Gln
290 295 300
Gly Thr His Asp Trp Lys Glu Ser Asp Ile Glu Leu Met Gln Ala Gly
305 310 315 320
Ala Lys Thr Leu Ala Thr Ser Pro Tyr Ile Leu Glu
325 330
<210> 3
<211> 175
<212> PRT
<213>Algae PCC7120
<400> 3
Gln Gln Tyr Gln His Thr Leu Leu Leu Lys Gln Ile Thr Glu Glu Ile
1 5 10 15
Arg Gln Ser Leu Gln Trp Glu Lys Ile Leu Lys Thr Thr Val Thr Glu
20 25 30
Val Gln Arg Ile Leu Gln Val Asp Arg Ala Leu Ile Phe Gln Ile Asn
35 40 45
Ser Asp Gly Ser Gly Lys Val Val Gln Glu Ala Val Met Pro Gly Trp
50 55 60
Ser Val Thr Leu Asp Gln Asp Ile Tyr Asp Pro Cys Leu Lys Asp Gly
65 70 75 80
Tyr Leu Asn Met Tyr Arg Asp Gly Arg Ile Thr Ala Ile Ala Asp Val
85 90 95
Tyr Gln Gly Gly Leu Lys Pro Cys Tyr Val Glu Phe Leu Gln Gln Phe
100 105 110
Gln Val Lys Ala Asn Leu Val Val Pro Ile Arg Val Arg Arg Asn Leu
115 120 125
Trp Gly Leu Leu Ile Val His Gln Cys Asp Arg Pro Arg Gln Trp Thr
130 135 140
Glu Leu Glu Leu Asp Leu Leu Lys His Leu Ala Asp Gln Met Gly Ile
145 150 155 160
Ala Leu Thr Gln Ser Gln Leu Leu Ala Gln Glu Thr Arg Gln Ala
165 170 175
<210> 4
<211> 329
<212> PRT
<213>Fusion protein
<400> 4
Met Gly Ser Ser His His His His His His Ser Gln Asp Pro Glu Ala
1 5 10 15
Gly Ile Thr Gly Thr Trp Tyr Asn Gln Leu Gly Ser Thr Phe Ile Val
20 25 30
Thr Ala Gly Ala Asp Gly Ala Leu Thr Gly Thr Tyr Glu Ser Ala Val
35 40 45
Gly Asn Ala Glu Ser Arg Tyr Val Leu Thr Gly Arg Tyr Asp Ser Ala
50 55 60
Pro Ala Thr Asp Gly Ser Gly Thr Ala Leu Gly Trp Thr Val Ala Trp
65 70 75 80
Lys Asn Asn Tyr Arg Asn Ala His Ser Ala Thr Thr Trp Ser Gly Gln
85 90 95
Tyr Val Gly Gly Ala Glu Ala Arg Ile Asn Thr Gln Trp Leu Leu Thr
100 105 110
Ser Gly Thr Thr Glu Ala Asn Ala Trp Lys Ser Thr Leu Val Gly His
115 120 125
Asp Thr Phe Thr Lys Val Lys Pro Ser Ala Ala Ser Gly Ser Gly Thr
130 135 140
Asp Asp Asp Asp Lys Ala Met Ala Asp Gly Gln Gln Tyr Gln His Thr
145 150 155 160
Leu Leu Leu Lys Gln Ile Thr Glu Glu Ile Arg Gln Ser Leu Gln Trp
165 170 175
Glu Lys Ile Leu Lys Thr Thr Val Thr Glu Val Gln Arg Ile Leu Gln
180 185 190
Val Asp Arg Ala Leu Ile Phe Gln Ile Asn Ser Asp Gly Ser Gly Lys
195 200 205
Val Val Gln Glu Ala Val Met Pro Gly Trp Ser Val Thr Leu Asp Gln
210 215 220
Asp Ile Tyr Asp Pro Cys Leu Lys Asp Gly Tyr Leu Asn Met Tyr Arg
225 230 235 240
Asp Gly Arg Ile Thr Ala Ile Ala Asp Val Tyr Gln Gly Gly Leu Lys
245 250 255
Pro Cys Tyr Val Glu Phe Leu Gln Gln Phe Gln Val Lys Ala Asn Leu
260 265 270
Val Val Pro Ile Arg Val Arg Arg Asn Leu Trp Gly Leu Leu Ile Val
275 280 285
His Gln Cys Asp Arg Pro Arg Gln Trp Thr Glu Leu Glu Leu Asp Leu
290 295 300
Leu Lys His Leu Ala Asp Gln Met Gly Ile Ala Leu Thr Gln Ser Gln
305 310 315 320
Leu Leu Ala Gln Glu Thr Arg Gln Ala
325

Claims (10)

1. a kind of fusion protein, GAF structural domains and Streptavidin including cyanobacteria phytochrome protein alr3356.
2. fusion protein according to claim 1, it is characterised in that：Affinity labeling is also added in fusion protein.
3. fusion protein according to claim 1, it is characterised in that：The sequence of fusion protein is： MGSSHHHHHHSQDPEAGITGTWYNQLGSTFIVTAGADGALTGTYESAVGNAESRYVLTGRYDSAPATDGSGTALGWT VAWKNNYRNAHSATTWSGQYVGGAEARINTQWLLTSGTTEANAWKSTLVGHDTFTKVKPSAASGSGTDDDDKAMADG MQIHSHAEFDPSSNKPTEQGLQKVLQRLVQTMQRDALVRQTTNQLRESLQVDRVVLYYFYWQWHGQVTFEALSSEEF SILGSTGADECFNDEYAALYLAGRTKAIADIESEPITTCHRDFLRTLQVRANLVVPVLVPKGLWGLLVAHHCQGTHD WKESDIELMQAGAKTLATSPYILE。
4. express the nucleotide sequence of fusion protein described in claims 1 or 2.
5. nucleotide sequence according to claim 3, it is characterised in that：Nucleotide sequence carries out codon according to host strain Optimization.
6. the plasmid inserted with the nucleotide sequence of claim 3 or 4.
7. plasmid according to claim 5, it is characterised in that：Plasmid is pET Duet vector plasmids, and nucleotide sequence leads to Cross the multiple cloning sites 1 that restriction enzyme site BamH I, EcoR I are inserted into pET Duet vector plasmids.
8. a kind of preparation method of fusion protein, includes the following steps：
1) sequence of fusion protein according to claim 1 or claim 2, design obtain antigen-4 fusion protein gene sequence；
2) antigen-4 fusion protein gene sequence is inserted into plasmid, obtains fusion protein plasmid；
3) by fusion protein plasmid and the related gene of expression phycoerythrobilin synthesis：Heme oxidase gene ho1, biliverdin is also The plasmid corotation of nitroreductase gene pebS enters Escherichia coli, obtains genetic engineering bacterium；
4) it is inoculated with genetic engineering bacterium in the medium using three-level inoculation method, 37 DEG C of fermented and cultureds are to growing early period；
5) 20 DEG C are cooled to, cultivates 0.8~1.2h；
6) 25 DEG C are warming up to, adds in 14~16h of lactose Fiber differentiation that whole mass concentration is 1.3~1.6%；
7) thalline extraction is collected, purifying obtains fusion protein.
9. preparation method according to claim 8, it is characterised in that：The quality group of fermentation medium becomes：Peptone 1%, dusty yeast 0.5%, sodium chloride 1%, glycerine 0.4%, 0.004%~0.04% proteinic powder of porcine or ferroheme, surplus For water, pH value is adjusted to 7.2.
10. preparation method according to claim 8 or claim 9, it is characterised in that：Add in the lactose that whole mass concentration is 1.5% Fiber differentiation.
CN201711462380.0A 2017-12-28 2017-12-28 A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome Pending CN108251441A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711462380.0A CN108251441A (en) 2017-12-28 2017-12-28 A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711462380.0A CN108251441A (en) 2017-12-28 2017-12-28 A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome

Publications (1)

Publication Number Publication Date
CN108251441A true CN108251441A (en) 2018-07-06

Family

ID=62724391

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711462380.0A Pending CN108251441A (en) 2017-12-28 2017-12-28 A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome

Country Status (1)

Country Link
CN (1) CN108251441A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019195A1 (en) * 1992-03-20 1993-09-30 Novo Nordisk A/S A process for producing heme proteins
CN1221453A (en) * 1996-06-10 1999-06-30 诺沃诺尔迪斯克生物技术有限公司 Method for increasing hemoprotein production in filamentous fungi
CN101397555A (en) * 2007-09-27 2009-04-01 广州天宝颂原生物科技开发有限公司 Method for preparing streptavidin marked allophycocyanins fluorescence protein
CN106916839A (en) * 2015-12-25 2017-07-04 中国科学院海洋研究所 A kind of preparation method of the recombinant phycobiliprotein concatermer of high fluorescent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019195A1 (en) * 1992-03-20 1993-09-30 Novo Nordisk A/S A process for producing heme proteins
CN1221453A (en) * 1996-06-10 1999-06-30 诺沃诺尔迪斯克生物技术有限公司 Method for increasing hemoprotein production in filamentous fungi
CN101397555A (en) * 2007-09-27 2009-04-01 广州天宝颂原生物科技开发有限公司 Method for preparing streptavidin marked allophycocyanins fluorescence protein
CN106916839A (en) * 2015-12-25 2017-07-04 中国科学院海洋研究所 A kind of preparation method of the recombinant phycobiliprotein concatermer of high fluorescent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
孙雅芳: "蓝细菌光受体色素化及晶体结构研究", 《中国博士学位论文全文数据库》 *

Similar Documents

Publication Publication Date Title
JP5895004B2 (en) Recombinant E. coli and its application in the production of 5-aminolevulinic acid
CN103525852A (en) High-throughput screening method of recombinant bacteria based on combination of self-induction culture and chromatic substrate
CN108250304A (en) A kind of preparation method of the cyanobacteria phytochrome fluorescent marker of fluorescent orange
CN102994425A (en) Genetic recombination escherichia coli and method for efficiently producing pullulanase
CN105950579B (en) Method for extracellular production of starch branching enzyme without signal peptide
ES2612252T3 (en) E. coli strain BL21 lacking a functional gene complex of group II capsular genes
CN101838661B (en) Preparation method of high stability phycocyanin fuse fluorescent protein
CN108148141A (en) A kind of preparation method of the cyanobacteria phytochrome fluorescent marker of green fluorescence
CN108148140A (en) A kind of preparation method of the yellow-green fluorescence marker of streptavidin fusion phytochrome
CN108164604A (en) A kind of preparation method of yellow fluorescence marker derived from phytochrome
CN108047334A (en) A kind of preparation method of the cyanobacteria phytochrome fluorescent marker of fluorescent red-orange
CN113564183A (en) Method for improving synthesis of prodigiosin by serratia marcescens through overexpression gene psrA
CN103695405B (en) A kind of production method of novel ss-lactam class antibiotic synthetic enzymes
CN109520985B (en) Method for rapidly detecting yield of glycolic acid in escherichia coli
CN108251441A (en) A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome
CN108148139A (en) A kind of preparation method of yellow fluorescence marker derived from phytochrome
CN108164605A (en) A kind of preparation method of the fluorescent marker of streptavidin fusion phytochrome
CN111394289A (en) Genetically engineered bacterium and application thereof, and method for producing prostaglandin E2
CN109486871A (en) A method of utilizing bacillus licheniformis engineered strain fermenting and producing 3-hydroxy-2-butanone
CN103060255B (en) Genetically engineering bacterium capable of producing S-3-hydroxy-butanone as well as construction method and application thereof
CN103088434B (en) Construction method and application of Pichia stipitis large-fragment DNA (deoxyribonucleic acid) genome library
CN113549643B (en) Method for improving synthesis of prodigiosin by Serratia marcescens through overexpression of gene psrB
CN112646831A (en) Shuttle plasmid, construction method and application thereof in synechocystis transformation exogenous gene
CN102712932B (en) Modified nucleotide molecules of xylanase and application thereof
CN111893107A (en) Pichia pastoris engineering strain for heterologous expression of cellulase gene EG IV and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180706